Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
German economic institutes cut forecast in half over Iran war - 2Watch the Geminid meteor shower peak tonight from the comfort of home with this free livestream
- 3The most effective method to Safeguard Your Teeth from Acidic Food varieties and Beverages
- 4Step by step instructions to Figure out the Natural Effect of 5G Pinnacles
- 5Middle East hotels hit pandemic-era lows amid Iran war
- Spain breaks jobs record with 22 million Social Security contributors
- China Just Got Another Cheap EV America Would Love to Have
- From Dread to Certainty: Individual Accounts of Strengthening
- Russia downs 16 drones heading for Moscow, mayor says
- Lower-cost space missions like NASA's ESCAPADE are starting to deliver exciting science – but at a price in risk and trade‑offs
- Moving Wedding Objections for Paramount Functions
- Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
- Israeli naval intelligence reduces Iranian threat to Strait of Hormuz
- Fact Check: Some Bridge Photos Circulating Do NOT Show The Hongqi Bridge That Collapsed In Southwest China Nov. 11, 2025
